Spyre Therapeutics (SYRE) Earnings Date, Estimates & Call Transcripts $12.82 -1.27 (-8.98%) As of 02:57 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Spyre Therapeutics Earnings Summary Upcoming Earnings DateMay. 8Before Market OpensEstimatedConsensus EPS (Feb. 27) -$0.89 Actual EPS (Feb. 27) -$0.81 Beat By $0.08 Spyre Therapeutics posted Q4 2024 earnings on February 27, 2025, reporting an EPS of -$0.81, which topped analysts' consensus estimates of -$0.89 by $0.08. With a trailing EPS of -$4.23, Spyre Therapeutics' earnings are expected to grow next year, from ($4.46) to ($3.99) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Report Annual Report (10-K)SEC FilingSYRE Upcoming EarningsSpyre Therapeutics' Q1 2025 earnings is scheduled for Thursday, May 8, 2025Powered by Get Spyre Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Spyre Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataSYRE Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SYRE Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Spyre Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.86-$0.83-$0.85Q2 20252-$0.83-$0.78-$0.81Q3 20252-$0.84-$0.75-$0.80Q4 20252-$0.85-$0.76-$0.81 Spyre Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/8/2025(Estimated)--------2/27/2025Q4 2024-$0.89-$0.81+$0.08-$0.81$2.10M-11/7/2024--$0.80-$1.36 -$0.56-$1.36--8/7/2024--$0.90-$0.86+$0.04-$0.86--5/13/2024--$0.90-$1.20 -$0.30-$1.20--2/29/2024Q4 2023-$0.48-$2.28 -$1.80-$0.51--11/9/2023Q3 2023-$0.44-$3.43 -$2.99$2.48--8/11/2023Q2 2023-$4.50-$41.50 -$37.00-$26.25-$0.69M5/11/2023Q1 2023-$4.75-$5.00 -$0.25-$5.00$0.17M$0.20M Spyre Therapeutics Earnings - Frequently Asked Questions When is Spyre Therapeutics's earnings date? Spyre Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 8th, 2025 based off last year's report dates. Learn more on SYRE's earnings history. Did Spyre Therapeutics beat their earnings estimates last quarter? In the previous quarter, Spyre Therapeutics (NASDAQ:SYRE) reported ($0.81) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.89) by $0.08. Learn more on analysts' earnings estimate vs. SYRE's actual earnings. How can I view Spyre Therapeutics's earnings report? Spyre Therapeutics's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Spyre Therapeutics generate each year? Spyre Therapeutics (NASDAQ:SYRE) has a recorded annual revenue of $890,000.00. How much profit does Spyre Therapeutics generate each year? Spyre Therapeutics (NASDAQ:SYRE) has a recorded net income of -$338.79 million. SYRE has generated -$4.23 earnings per share over the last four quarters. What is Spyre Therapeutics's EPS forecast for next year? Spyre Therapeutics's earnings are expected to grow from ($4.46) per share to ($3.99) per share in the next year. More Earnings Resources from MarketBeat Related Companies SpringWorks Therapeutics Earnings Results Organon & Co. Earnings Results Merus Earnings Results Crinetics Pharmaceuticals Earnings Results Scholar Rock Earnings Results Akero Therapeutics Earnings Results Viking Therapeutics Earnings Results Xenon Pharmaceuticals Earnings Results Catalyst Pharmaceuticals Earnings Results Protagonist Therapeutics Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Palantir Stock Drops Despite Stellar Earnings: What's Next?Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?Is Reddit Stock a Buy, Sell, or Hold After Earnings Release?Warning or Opportunity After Super Micro Computer's EarningsAmazon Earnings: 2 Reasons to Love It, 1 Reason to Be CautiousRocket Lab Braces for Q1 Earnings Amid Soaring ExpectationsMeta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2 This page (NASDAQ:SYRE) was last updated on 5/6/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredConfidential Economic AdvisoryI've hesitated for months to record this video. The very act of sharing these details makes me deeply uncom...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spyre Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Spyre Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SYRE Stock Free SYRE Stock Alerts